Fmoc-L-Aza-OH

Fmoc-L-Aza-OH is an Fmoc-protected L-aza amino acid building block designed for solid-phase and solution-phase peptide chemistry. The molecule contains an Fmoc carbamate on the amino functionality, a carboxylic acid handle for amide bond formation, and an aza-substituted side-chain motif that introduces an additional nitrogen-containing heteroatom environment for hydrogen-bonding and polarity modulation. The L stereochemistry provides a defined chiral center for stereocontrolled incorporation into peptide sequences or peptidomimetic scaffolds, while the Fmoc group supports orthogonal protection strategies compatible with standard base-labile deprotection. The presence of a free carboxylic acid enables coupling to activated esters or coupling reagents, and the aza functionality can participate in further derivatization or heteroatom-directed binding studies in downstream analogs.

1. Peptide Synthesis

Fmoc-L-Aza-OH is used in peptide building block preparation for both automated solid-phase peptide synthesis and carefully controlled solution-phase coupling workflows. The Fmoc-protected amino group supports orthogonal protection, enabling iterative peptide chain assembly with base-mediated Fmoc removal while retaining the carboxylic acid for amide bond formation. The aza-containing side-chain provides a nitrogen-rich microenvironment that can influence local conformation and intermolecular interactions in the resulting peptide or peptidomimetic. Incorporation of this chiral L-aza residue can be applied to generate peptide libraries, sequence-specific analogs, and backbone-modified constructs where heteroatom placement is used as a structure-function probe.

2. Peptidomimetics And SAR Studies

Fmoc-L-Aza-OH is applied in medicinal chemistry research workflows focused on peptidomimetic construction and structure-activity relationship studies. The aza side-chain functionality can be leveraged to tune polarity, hydrogen-bonding capacity, and metal-ion or receptor-interface interactions without introducing large hydrophobic groups. The stereodefined L configuration helps maintain consistent spatial presentation of the aza heteroatom relative to the peptide backbone, supporting reproducible SAR comparisons across analog series. The Fmoc-protected amino acid format also supports rapid incorporation into defined scaffolds, enabling systematic evaluation of how aza placement and side-chain electronics affect binding-relevant properties.

3. Chemical Biology Conjugation

Fmoc-L-Aza-OH is suitable for chemical biology programs that require amino acid-derived handles for biomolecule labeling and conjugation chemistry. The carboxylic acid enables formation of amide-linked intermediates that can be coupled to linkers, affinity tags, or reporter-bearing moieties under standard peptide-coupling conditions. The nitrogen-containing aza functionality can serve as a hydrogen-bonding element within conjugates, potentially improving solubility and interaction specificity in assay environments. Fmoc-L-Aza-OH can be incorporated into short peptides used as targeting or recognition motifs, then carried forward into bioconjugation strategies that rely on stable amide connectivity and defined stereochemistry.

4. Protected Amino Acid Chemistry

Fmoc-L-Aza-OH is employed as an Fmoc-protected amino acid derivative for protected amino acid synthesis and intermediate preparation in synthetic organic chemistry. The Fmoc carbamate provides a robust, base-labile protecting group for the amino functionality, supporting orthogonal deprotection sequences when additional protecting groups are present on other residues or side chains. The free carboxylic acid enables conversion to activated derivatives or direct coupling partners, supporting downstream synthesis of longer peptides, cyclized analogs, or branched constructs. The chiral L-aza framework allows stereochemically defined incorporation into multi-step routes where maintaining configuration through coupling and deprotection is required for consistent structural outcomes.

5. Pharmaceutical Intermediate Preparation

Fmoc-L-Aza-OH is applicable to pharmaceutical intermediate preparation where amino acid-derived fragments are used to build defined peptidic or peptidomimetic motifs. The combination of an Fmoc-protected amine and a carboxylic acid provides a manufacturable, isolable format that can be integrated into fragment assembly strategies and controlled coupling steps during fine chemical synthesis. The aza-containing side-chain can be used to introduce heteroatom functionality that supports solubility tuning and binding-interface interactions in peptide-like intermediates. The compound's compatibility with peptide coupling chemistry and orthogonal protection logic makes it suitable for producing stereochemically defined intermediates that can be carried into broader industrial synthetic sequences.

1. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

2. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

3. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

5. Cationic cell-penetrating peptides are potent furin inhibitors